Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients

J Pediatric Infect Dis Soc. 2018 Feb 19;7(1):e6-e8. doi: 10.1093/jpids/pix076.

Authors

Hira Bluestone¹, Matthew P Kronman^{1

2}, David L Suskind^{2

3}

Affiliations

¹ Division of Infectious Diseases, Department of Pediatrics, University of Washington, Seattle.
² Center for Clinical and Translational Research, Seattle Children's Hospital Research Institute, Washington.
³ Division of Gastroenterology, Department of Pediatrics, University of Washington, Seattle.

PMID: 29040661
DOI: 10.1093/jpids/pix076

No abstract available

Publication types

Case Reports

MeSH terms

Child
Clostridioides difficile / isolation & purification
Clostridium Infections / etiology
Clostridium Infections / therapy*
DiGeorge Syndrome / therapy
Fecal Microbiota Transplantation*
Feces / microbiology
Female
Hematopoietic Stem Cell Transplantation / adverse effects*
Humans
Immunocompromised Host
Leukemia, Myeloid, Acute / therapy
Male
Mucopolysaccharidosis I / therapy
Recurrence